International

Kaposi's sarcoma treatment in Kenya and Nigeria

  • Principal Investigator(s): Esther Freeman
  • Study Contact: efreeman@mgh.harvard.edu
  • Description of Subjects: Adults with HIV-related Kaposi's sarcoma in Kenya and Nigeria
  • Location (Domestic vs. International): AMPATH (Eldoret, Kenya), Institute of Human Virology (Abuja, Nigeria)
  • Enrollment Period: 2009-2012
  • Enrollment Goal: All KS patients diagnosed at these sites during enrollment period

Cotrimoxazole safety study

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Infants born to HIV-infected women
  • Location (Domestic vs. International): Botswana
  • Enrollment Period: 2008-2009
  • Enrollment Goal: 444 mother-infant pairs

Botswana Prospective Cancer Cohort

  • Principal Investigator(s): Scott Dryden-Peterson
  • Study Contact: Scott Dryden-Peterson, +2.677.447.2522, scott_peterson@post.harvard.edu
  • Description of Subjects: Botswana adults with a new diagnosis of cancer
  • Location (Domestic vs. International): Botswana Harvard AIDS Institute
  • Enrollment Period: 2010-ongoing
  • Enrollment Goal: 3000

Uganda AIDS Rural Treatment Outcomes Cohort Study

  • Principal Investigator(s): David Bangsberg, MD
  • Study Contact: Rachel Rifkin617.724.3194rrifkin@partners.org
  • Description of Subjects: All patients over 18 years and initiating ART at the Mbarara Immune Suppression Syndrome Clinic who lived within 60 kilometers from the clinic
  • Location (Domestic vs. International): Mbarara, Uganda

HIV-associated Seizures and Epilepsy in Zambia

  • Principal Investigator(s): Omar K. Siddiqi
  • Study Contact: Omar K. Siddiqi, +260 979365956, osiddiqi@bidmc.harvard.edu
  • Description of Subjects: HIV+ adults with new onset seizure
  • Location (Domestic vs. International): Lusaka, Zambia - University of Zambia School of Medicine
  • Enrollment Period: 2011 - 2013
  • Enrollment Goal: 100

Mothers and Infants Botswana PMTCT trial

  • Principal Investigator(s): Roger Shapiro
  • Study Contact: Roger Shapiro, 617-771-0040,rshapiro@hsph.harvard.edu
  • Description of Subjects: 730 mothers and infants in a Botswana PMTCT trial
  • Location (Domestic vs. International): International, Botswana
  • Enrollment Period: 2006-2008
  • Enrollment Goal: 730